https://www.ucsf.edu/news/2016/09/404271/induced-pluripotent-stem-cells-10-years-after-breakthrough
Open the link above, and then read below. From Shaw and Partners
http://cynata.com/wp-content/uploads/2016/09/Shaws-Flash-Note-Fujifilm-06Sept16.pdf
- the fact that CymerusTM is the only technology for generating medicinal MSCs from iPS cells, that it is increasingly viewed as a likely therapeutic solution.
- CYP has the most valuable part of the solution
There are a number of autologous4 5 processes for generating differentiated cells from iPS cells, however CYP’s Cymerus is the only commercially scalable technology that can make off the shelf MSCs that can be used inside human bodies for therapeutic purposes.
induced-pluripotent-stem-cells
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $26.24K | 131.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78722 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 15873 | 1 |
View Market Depth
| Last trade - 15.34pm 16/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |